Firethorn Wealth Partners, LLC Dynavax Technologies Corp Transaction History

Firethorn Wealth Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	SELL	$9.85 - $13.17 $98 - $131	-10 Reduced 0.08%	11,970 $154,000
Q1 2023 May 02, 2023	SELL	$9.44 - $11.88 $118,472 - $149,094	-12,550 Reduced 51.16%	11,980 $117,000
Q4 2022 Feb 07, 2023	SELL	$10.27 - $13.29 $232,574 - $300,965	-22,646 Reduced 48.0%	24,530 $260,000
Q3 2022 Oct 18, 2022	SELL	$9.93 - $17.44 $1,986 - $3,488	-200 Reduced 0.42%	47,176 $493,000
Q2 2022 Aug 03, 2022	BUY	$7.45 - $12.83 $789 - $1,359	106 Added 0.22%	47,376 $665,000
Q1 2022 May 03, 2022	BUY	$9.75 - $14.44 $105,202 - $155,807	10,790 Added 29.58%	47,270 $512,000
Q4 2021 Feb 08, 2022	BUY	$13.17 - $20.94 $227,577 - $361,843	17,280 Added 90.0%	36,480 $513,000
Q2 2021 Jul 20, 2021	BUY	$7.25 - $10.99 $47,850 - $72,534	6,600 Added 52.38%	19,200 $189,000
Q1 2021 May 18, 2021	BUY	$4.57 - $11.18 $57,582 - $140,868	12,600 New	12,600 $124,000

274

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.57B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Firethorn Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Firethorn Wealth Partners, LLC with notifications on news.